18 results
8-K
EX-99.1
XLO
Xilio Therapeutics Inc
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
to build upon our strong scientific foundation and continue our rapid pace of innovation and execution,” said Dr. Coleman. “Xilio’s shared commitment
8-K
EX-99.2
2ebql7
12 May 22
Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results
7:36am
10-K
410if2x
1 Mar 22
Annual report
4:07pm
10-Q
zrc gou5t86g
2 Dec 21
Quarterly report
4:15pm
424B4
x4kaa 8hu9u
22 Oct 21
Prospectus supplement with pricing info
4:02pm
S-1/A
y5t00ka
18 Oct 21
IPO registration (amended)
6:04am
S-1
5hw6x
1 Oct 21
IPO registration
4:49pm
DRS/A
5ibux
14 Sep 21
Draft registration statement (amended)
12:00am
DRS
xym7cq
24 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next